Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 3)
    https://pixabay.com/en/american-football-football-sports-1666276/

    INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 3)

    Before you read on, make sure to check out: Part 1 of our article: Green Bay Packers' Shemar Jean-Charles and Los Angeles Chargers' Storm Norton discuss why they raise Alzheimer's disease…

    Continue Reading INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 3)
    INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 2)
    Photo: https://unsplash.com/photos/Yta-zdP9PVM

    INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 2)

    Before you read on, make sure to check out Part 1 of our article. In Part 1, Green Bay Packers Cornerback Shemar Jean-Charles discusses why he supports the Alzheimer's Association and how…

    Continue Reading INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 2)
    ICYMI: VGA039, a First-in-Class Antibody Therapy for VWD, Launched at ASH Annual Meeting
    source: pixabay.com

    ICYMI: VGA039, a First-in-Class Antibody Therapy for VWD, Launched at ASH Annual Meeting

      The 65th American Society of Hematology (ASH) Annual Meeting took place from December 10-13, 2022. During the meeting, stakeholders in the hematology field came together to discuss trends, research,…

    Continue Reading ICYMI: VGA039, a First-in-Class Antibody Therapy for VWD, Launched at ASH Annual Meeting
    INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 1)
    Source: Pixabay.com

    INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 1)

    From September to January each year, our home transforms; each Sunday, my boyfriend and I meticulously set up our living room, make snacks, and spend the day watching football on…

    Continue Reading INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 1)
    A Ray of Sunshine: Alex Gaudlap’s Efforts to Raise Awareness of the Ultra-Rare VAMP2 (Pt. 2)
    Raymond and Alex in 2022. Photo courtesy of Alex Gaudlap

    A Ray of Sunshine: Alex Gaudlap’s Efforts to Raise Awareness of the Ultra-Rare VAMP2 (Pt. 2)

    Before you read on, don't forget to check out Part 1 of our interview. In Part 1, Alex discusses the multi-year diagnostic odyssey to discover that Raymond has VAMP2. Today, we talk…

    Continue Reading A Ray of Sunshine: Alex Gaudlap’s Efforts to Raise Awareness of the Ultra-Rare VAMP2 (Pt. 2)
    A Ray of Sunshine: Alex Gaudlap’s Efforts to Raise Awareness of the Ultra-Rare VAMP2 (Pt. 1)
    Raymond and Alex in 2022. Photo courtesy of Alex Gaudlap

    A Ray of Sunshine: Alex Gaudlap’s Efforts to Raise Awareness of the Ultra-Rare VAMP2 (Pt. 1)

    In the United States, rare diseases are defined as those affecting fewer than 200,000 people. In the cases of ultra-rare conditions, there is often even less research, less resources, and…

    Continue Reading A Ray of Sunshine: Alex Gaudlap’s Efforts to Raise Awareness of the Ultra-Rare VAMP2 (Pt. 1)
    How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 2)
    [Source: Pixabay.com]

    How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 2)

    Before you read on, don't forget to check out Part 1 of our interview. In Part 1, Wendy discusses what hypertrophic cardiomyopathy (HCM) is, her rare variant, the diagnostic journey, and her…

    Continue Reading How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 2)
    Finding Balance with CDKL5 Deficiency Disorder: Whitney and Havilah’s Story (Pt. 1)
    Photo courtesy of Whitney Mitchell

    Finding Balance with CDKL5 Deficiency Disorder: Whitney and Havilah’s Story (Pt. 1)

    A year after her daughter Havilah was diagnosed with CDKL5 deficiency disorder (CDD), Whitney Mitchell’s pediatrician looked her in the eyes and said something that Whitney still carries with her…

    Continue Reading Finding Balance with CDKL5 Deficiency Disorder: Whitney and Havilah’s Story (Pt. 1)
    Gene Therapy Saves Boy with ALD
    source: pixabay.com

    Gene Therapy Saves Boy with ALD

      Growing up, Priscilla Veneklause watched as her father struggled to manage his rare genetic disorder: adrenoleukodystrophy (ALD). Unfortunately, her father lost his fight with ALD when Priscilla was still…

    Continue Reading Gene Therapy Saves Boy with ALD

    INTERVIEW: Albireo’s CEO Ron Cooper Talks Patient-Centricity, PFIC, and Study Updates

    Each week, in an email to his team, Albireo Pharma CEO Ron Cooper sends out the story of a child or family affected by conditions such as PFIC or Alagille…

    Continue Reading INTERVIEW: Albireo’s CEO Ron Cooper Talks Patient-Centricity, PFIC, and Study Updates
    How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 1)
    source: pixabay.com

    How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 1)

    Wendy Borsari is not just a patient living with hypertrophic cardiomyopathy (HCM); she is also a mother, a fierce advocate, and part of the patient advocacy team at Tenaya Therapeutics,…

    Continue Reading How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 1)
    Researchers Find Potential Congenital Hyperinsulinism Cause in Unexplored Genomic Region
    qimono / Pixabay

    Researchers Find Potential Congenital Hyperinsulinism Cause in Unexplored Genomic Region

      There are a number of different forms of congenital hyperinsulinism, along with a variety of different causes: a mother’s unmanaged diabetes, premature birth, gene mutations. But up to half…

    Continue Reading Researchers Find Potential Congenital Hyperinsulinism Cause in Unexplored Genomic Region